Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Portal Hypertension to Cardiovascular Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Portal Hypertension to Cardiovascular Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Portal Hypertension Therapeutics Clinical Trials 27
Prominent Drugs 28
Latest Clinical Trials News on Portal Hypertension 29
Sep 14, 2016: Cumberland Pharmaceuticals Announces New Program To Develop Portaban For Portal Hypertension 29
Clinical Trial Profile Snapshots 30
Appendix 96
Abbreviations 96
Definitions 96
Research Methodology 97
Secondary Research 97
About GlobalData 98
Contact Us 98
Disclaimer 98
Source 99

List of Tables
Portal Hypertension Therapeutics, Global, Clinical Trials by Region, 2016* 6
Portal Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Portal Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Portal Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Portal Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Portal Hypertension Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Portal Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
Portal Hypertension Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 13
Proportion of Portal Hypertension to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 14
Portal Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Portal Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Portal Hypertension to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 17
Portal Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Portal Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Portal Hypertension Therapeutics, Global, Clinical Trials by Phase, 2016* 20
Portal Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
Portal Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Portal Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Portal Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Portal Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
Portal Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Portal Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Portal Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28

List of Figures
Portal Hypertension Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Portal Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Portal Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Portal Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Portal Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Portal Hypertension Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Portal Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12
Portal Hypertension Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 13
Proportion of Portal Hypertension to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 14
Portal Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Portal Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Portal Hypertension to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 17
Portal Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Portal Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Portal Hypertension Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
Portal Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
Portal Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Portal Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Portal Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Portal Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
Portal Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Portal Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Portal Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
GlobalData Methodology 97